NCT03306667View on ClinicalTrials.gov

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

June 20, 2018

Study Completion Date

June 25, 2018

Conditions
Hepatic InsufficiencyHealthy
Interventions
DRUG

FYU-981

Oral single dosing

Trial Locations (1)

Unknown

Mochida Investigational sites, Tokyo

Sponsors

Collaborators (1)

Fuji Yakuhin Co., Ltd.
All Listed Sponsors
collaborator

Fuji Yakuhin Co., Ltd.

INDUSTRY

lead

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

NCT03306667 - Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency) | Biotech Hunter | Biotech Hunter